6-{[3-(2-Chloro-phenyl)-5-methyl-isoxazole-4-carbonyl]-amino}-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid | 7060-81-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 6-{[3-(2-Chloro-phenyl)-5-methyl-isoxazole-4-carbonyl]-amino}-3,3-dimethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid
• 英文别名: 6-<3-(2-Chlorphenyl)-5-methyl-4-isoxazolcarboxamido>-2,2-dimethylpenam-3-carboxylat；6-{[3-(2-Chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid；6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
• CAS: 7060-81-3
• 化学式: C₁₉H₁₈ClN₃O₅S
• 分子量: 435.888
• InChiKey: LQOLIRLGBULYKD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  29
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  138
• 氢给体数：
  2
• 氢受体数：
  7

ADMET

毒理性

• 在妊娠和哺乳期间的影响

◉ 母乳喂养期间使用总结：有限的信息表明，氯唑西林在乳汁中产生的水平较低，预计不会对哺乳婴儿造成不良影响。偶尔有报道指出，青霉素类药物可能会破坏婴儿的胃肠道菌群，导致腹泻或鹅口疮，但这些影响尚未得到充分评估。对于哺乳期母亲来说，氯唑西林是可以接受的。 ◉ 对哺乳婴儿的影响：在一项电话随访研究中，10位哺乳母亲报告使用氯唑西林（剂量未具体说明）。其中两位母亲报告其婴儿出现腹泻。在接触过药物的婴儿中没有报告出现皮疹或念珠菌病。 ◉ 对泌乳和母乳的影响：截至修订日期，没有找到相关的已发布信息。

◉ Summary of Use during Lactation:Limited information indicates that cloxacillin produces low levels in milk that are not expected to cause adverse effects in breastfed infants. Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush have been reported with penicillins, but these effects have not been adequately evaluated. Cloxacillin is acceptable in nursing mothers. ◉ Effects in Breastfed Infants:In a telephone follow-up study, 10 nursing mothers reported taking cloxacillin (dosage unspecified). Two mothers reported diarrhea in their infants. No rashes or candidiasis were reported among the exposed infants. ◉ Effects on Lactation and Breastmilk:Relevant published information was not found as of the revision date.

来源:Drugs and Lactation Database (LactMed)

文献信息

• [EN] IMPROVED PROCESS FOR PREPARING PENICILLINS AND INTERMEDIATE COMPOUNDS<br/>[FR] PROCÉDÉ AMÉLIORÉ DE PRÉPARATION DE PÉNICILLINES ET AUTRES COMPOSÉS INTERMÉDIAIRES
  申请人：VARDHMAN CHEMTECH LTD

  公开号：WO2012164355A1

  公开（公告）日：2012-12-06

  Disclosed is an improved process for the preparation of isoxazolyl penicillins of formula (I), wherein X1 and X2 can be independently selected from the group comprising hydrogen, chlorine or fluorine, and its pharmaceutically suitable salts. The process is economic in -situ synthetic method without isolation of any intermediate. (I).

  公开了一种改进的制备式(I)异噁唑基青霉素的方法，其中X1和X2可以独立地选择自氢、氯或氟的群体，以及其药用盐。该方法是一种经济的原位合成方法，无需分离任何中间体。(I)。
• US4181656A
  申请人：——

  公开号：US4181656A

  公开（公告）日：1980-01-01
• US4182709A
  申请人：——

  公开号：US4182709A

  公开（公告）日：1980-01-08